Lung Cancer
News, opinions and meeting coverage in pulmonology.
<ѻýҕl>ASCO: Platinum-Taxane Regimen No Benefit for Thymoma or Thymic Carcinoma
ѻýҕl>
CHICAGO -- For treatment-naive advanced thymoma or thymic carcinoma, carboplatin (Paraplatin) and paclitaxel (Taxol) failed to achieve response rates approaching those reported in published trials of athracycline-based regimens.
Jun 05, 2008
<ѻýҕl>Radiologists Take FDA Warning on Lung Ablation in Strideѻýҕl>
ROCKVILLE, Md. -- The FDA's recent warning about deaths caused by radiofrequency ablation of lung tumors was more a note of caution than a mortal blow to the procedure, said interventional radiologists experienced with the technique.
Feb 01, 2008
<ѻýҕl>ASCO: High Dose Pemetrexed (Alimta) Fails to Increase Survival in NSCLCѻýҕl>
CHICAGO -- Increasing the dose of pemetrexed (Alimta) to 900 mg/m2 did not improve outcome for patients with advanced non-small cell lung cancer (NSCLC), but did slightly increase toxicity, researchers found.
Jun 08, 2007